These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32185137)

  • 1. The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects.
    Fattizzo B; Rosa J; Giannotta JA; Baldini L; Fracchiolla NS
    Front Oncol; 2020; 10():273. PubMed ID: 32185137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
    Bardelli V; Arniani S; Pierini V; Di Giacomo D; Pierini T; Gorello P; Mecucci C; La Starza R
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
    Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
    PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
    Messina M; Chiaretti S; Wang J; Fedullo AL; Peragine N; Gianfelici V; Piciocchi A; Brugnoletti F; Di Giacomo F; Pauselli S; Holmes AB; Puzzolo MC; Ceglie G; Apicella V; Mancini M; Te Kronnie G; Testi AM; Vitale A; Vignetti M; Guarini A; Rabadan R; Foà R
    Oncotarget; 2016 Mar; 7(12):13886-901. PubMed ID: 26883104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
    Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
    Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update.
    Montaño A; Forero-Castro M; Marchena-Mendoza D; Benito R; Hernández-Rivas JM
    Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29642462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
    Pear WS; Aster JC
    Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting steroid resistance in T-cell acute lymphoblastic leukemia.
    De Smedt R; Morscio J; Goossens S; Van Vlierberghe P
    Blood Rev; 2019 Nov; 38():100591. PubMed ID: 31353059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma.
    Waibel M; Gregory G; Shortt J; Johnstone RW
    Curr Opin Hematol; 2014 Jul; 21(4):297-308. PubMed ID: 24811162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition.
    Courtois L; Cabannes-Hamy A; Kim R; Delecourt M; Pinton A; Charbonnier G; Feroul M; Smith C; Tueur G; Pivert C; Balducci E; Simonin M; Angel LH; Spicuglia S; Boissel N; Andrieu GP; Asnafi V; Rousselot P; Lhermitte L
    Blood; 2023 Jul; 142(2):158-171. PubMed ID: 37023368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.
    Bongiovanni D; Saccomani V; Piovan E
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28872614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies.
    Lodewijckx I; Cools J
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34066732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
    Valliyammai N; Nancy NK; Sagar TG; Rajkumar T
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e1-e8. PubMed ID: 29200162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.